Stefan Goldberg

5.1k total citations · 1 hit paper
46 papers, 3.2k citations indexed

About

Stefan Goldberg is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Stefan Goldberg has authored 46 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 27 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Stefan Goldberg's work include Tuberculosis Research and Epidemiology (36 papers), Mycobacterium research and diagnosis (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Stefan Goldberg is often cited by papers focused on Tuberculosis Research and Epidemiology (36 papers), Mycobacterium research and diagnosis (19 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Stefan Goldberg collaborates with scholars based in United States, Uganda and Canada. Stefan Goldberg's co-authors include Charles M. Nolan, Andrew Vernon, John Jereb, Susan E. Buskin, Kenneth G. Castro, Gerald H. Mazurek, Margarita E. Villarino, Timothy R. Sterling, John L. Johnson and William J. Burman and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Stefan Goldberg

46 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.

2010 843 citations Andrew Vernon, Stefan Goldberg et al. profile →

Peers

Stefan Goldberg

EPIDE

SURGE

PHARM

Rovina Ruslami Indonesia

John Jereb United States

Marc Weiner United States

Andrew Vernon United States

Charles D. Wells United States

Geraint Davies United Kingdom

Kwok Chiu Chang China

Kogieleum Naidoo South Africa

Lia D’Ambrosio Italy

Kelly E. Dooley United States

Rovina Ruslami Indonesia

Stefan Goldberg

2.0k ×0.7

1.4k ×0.7

EPIDE

1.1k ×0.7

SURGE

138 ×0.7

PHARM

298 ×1.5

Citations per year, relative to Stefan Goldberg Stefan Goldberg (= 1×) peers Rovina Ruslami

Countries citing papers authored by Stefan Goldberg

Since Specialization

Citations

This map shows the geographic impact of Stefan Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Goldberg more than expected).

Fields of papers citing papers by Stefan Goldberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Goldberg. The network helps show where Stefan Goldberg may publish in the future.

Co-authorship network of co-authors of Stefan Goldberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Goldberg. A scholar is included among the top collaborators of Stefan Goldberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Goldberg. Stefan Goldberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moro, Ruth N., Nigel Scott, Andrew Vernon, et al.. (2018). Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials. Annals of the American Thoracic Society. 15(5). 570–580. 42 indexed citations

Dorman, Susan E., Radojka M. Savić, Stefan Goldberg, et al.. (2014). Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial. American Journal of Respiratory and Critical Care Medicine. 191(3). 333–343. 76 indexed citations

Reves, Randall, Charles M. Heilig, Lorna Bozeman, et al.. (2014). Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance. The International Journal of Tuberculosis and Lung Disease. 18(5). 571–580. 10 indexed citations

Heilig, Charles M., Moses Joloba, John L. Johnson, et al.. (2014). How we determined the most reliable solid medium for studying treatment of tuberculosis. Tuberculosis. 94(3). 317–322. 3 indexed citations

Nyendak, Melissa, Byung Park, Megan Null, et al.. (2013). Mycobacterium tuberculosis Specific CD8+ T Cells Rapidly Decline with Antituberculosis Treatment. PLoS ONE. 8(12). e81564–e81564. 37 indexed citations

Hales, Craig M., Charles M. Heilig, Richard E. Chaisson, et al.. (2013). The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment. Annals of the American Thoracic Society. 10(1). 18–25. 18 indexed citations

Dorman, Susan E., Stefan Goldberg, Jason E. Stout, et al.. (2012). Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium. The Journal of Infectious Diseases. 206(7). 1030–1040. 85 indexed citations

Kenzie, William R. Mac, Charles M. Heilig, Lorna Bozeman, et al.. (2011). Geographic Differences in Time to Culture Conversion in Liquid Media: Tuberculosis Trials Consortium Study 28. Culture Conversion Is Delayed in Africa. PLoS ONE. 6(4). e18358–e18358. 26 indexed citations

Dorman, Susan E., John L. Johnson, Stefan Goldberg, et al.. (2009). Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(3). 273–280. 184 indexed citations

10.

Horsburgh, C. Robert, Timothy R. Sterling, James Bethel, et al.. (2006). The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada. American Journal of Respiratory and Critical Care Medicine. 174(4). 481–481. 2 indexed citations

11.

Burman, William J., Stefan Goldberg, John L. Johnson, et al.. (2006). Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 174(3). 331–338. 207 indexed citations

12.

Sterling, Timothy R., James Bethel, Stefan Goldberg, et al.. (2006). The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada. American Journal of Respiratory and Critical Care Medicine. 173(8). 927–931. 76 indexed citations

13.

Weiner, Marc, Naomi Bock, Charles A. Peloquin, et al.. (2004). Pharmacokinetics of Rifapentine at 600, 900, and 1,200 mg during Once-Weekly Tuberculosis Therapy. American Journal of Respiratory and Critical Care Medicine. 169(11). 1191–1197. 62 indexed citations

14.

Cangelosi, Gerard A., et al.. (2004). Evaluation of a High-Throughput Repetitive-Sequence-Based PCR System for DNA Fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium Complex Strains. Journal of Clinical Microbiology. 42(6). 2685–2693. 57 indexed citations

15.

Goldberg, Stefan, et al.. (1999). Four-Month, Four-Drug Preventive Therapy for Inactive Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 160(2). 508–512. 6 indexed citations

16.

Nolan, Charles M., Stefan Goldberg, & Susan E. Buskin. (1999). Hepatotoxicity Associated With Isoniazid Preventive Therapy. JAMA. 281(11). 1014–1014. 344 indexed citations

17.

Wells, Charles D., Patrick Zuber, Charles M. Nolan, Nancy Binkin, & Stefan Goldberg. (1997). Tuberculosis Prevention Among Foreign-born Persons in Seattle–King County, Washington. American Journal of Respiratory and Critical Care Medicine. 156(2). 573–577. 26 indexed citations

18.

Nolan, Charles M., et al.. (1997). Directly Observed Isoniazid Preventive Therapy for Released Jail Inmates. American Journal of Respiratory and Critical Care Medicine. 155(2). 583–586. 44 indexed citations

19.

Nolan, Charles M., Diana L. Williams, M. Donald Cave, et al.. (1995). Evolution of Rifampin Resistance in Human Immunodeficiency Virus-Associated Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 152(3). 1067–1071. 47 indexed citations

20.

Mekjavić, Igor B., Stefan Goldberg, J. B. Morrison, et al.. (1991). Exercise breathing pattern during chronic altitude exposure. European Journal of Applied Physiology. 62(1). 61–65. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact